Performed on the company's Safetube platform, GFC's Microscreen test uses DNA hybridization to detect biomarkers in methicillin-resistant Staphylococcus aureus.
In Science this week: new version of CRISPR that targets RNA, and more.
Using MRSA isolates from England, researchers uncovered hospital-specific, community-specific, and overlapping transmission clusters.
In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.
Scientists studied blood samples from 300 patients with septicemia, examining how different MRSA strains behave and assessing their lethality.
Scientists from The Wellcome Trust Sanger Institute, Public Health England, and elsewhere sequenced the genomes of 209 MRSA isolates collected in Europe from 1960 to 1989.
The financing will go toward efforts by the German firm to bring its point-of-care screening system for drug-resistant bacteria to hospitals.
The test, which simultaneously detects MRSA and Staphylococcus aureus, is designed to run on the company's Liat PCR point-of-care platform.
To develop the test, the firm said it used a library of MRSA strains collected around the world, and included components that reduce false positive results.
In Genome Biology this week: over-representation of European individuals in large datasets, methicillin-resistant Staphylococcus aureus clone in East Asia, and more.
A new analysis founds that nearly half the late-stage clinical trials sponsored by a US National Cancer Institute program influence patient care.
Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.
The owner of the GEDmatch website tells CBS12 he is considering charging law enforcement a fee to use the site.
In Nature this week: babies born by caesarean section are more likely to have altered gut microbiota profiles, and more.